Skip to main content

Table 1 Patient and tumor demographics and specimen sources

From: Clinical validation of a 90-gene expression test for tumor tissue of origin diagnosis: a large-scale multicenter study of 1417 patients

Characteristics

Number of specimens (N = 1417)

Percentage (%)

Study

  

 Retrospective

924

65.2

 Prospective

493

34.8

Centers

  

 BCH

518

36.6

 FUSCC

424

29.9

 ZCH

475

33.5

Age (year)

  

 Median

57

 Range

9–88

Gender

  

 Male

673

47.5

 Female

744

52.5

Histological type

  

 Adenocarcinoma

943

66.5

 Squamous cell carcinoma

166

11.7

 Urothelial carcinoma

55

3.9

 Melanoma

54

3.8

 Neuroendocrine tumor

52

3.7

 Tumor

49

3.5

 Sarcoma

46

3.2

 Germ cell tumor

40

2.8

 Mesothelioma

12

0.9

Histologic gradea

  

 Well-moderately differentiated

418

37.6

 Poorly differentiated/Undifferentiated

694

62.4

  1. BCH, Beijing Cancer Hospital; FUSCC, Fudan University Shanghai Cancer Center; ZCH, Zhejiang Cancer Hospital
  2. aThe differentiation of 305 cases are not defined